1. Home
  2. ALVOW vs TGTX Comparison

ALVOW vs TGTX Comparison

Compare ALVOW & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVOW
  • TGTX
  • Stock Information
  • Founded
  • ALVOW N/A
  • TGTX 1993
  • Country
  • ALVOW Luxembourg
  • TGTX United States
  • Employees
  • ALVOW 999
  • TGTX N/A
  • Industry
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • TGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALVOW Health Care
  • TGTX Health Care
  • Exchange
  • ALVOW Nasdaq
  • TGTX Nasdaq
  • Market Cap
  • ALVOW N/A
  • TGTX N/A
  • IPO Year
  • ALVOW N/A
  • TGTX 1995
  • Fundamental
  • Price
  • ALVOW $2.40
  • TGTX $33.09
  • Analyst Decision
  • ALVOW
  • TGTX Strong Buy
  • Analyst Count
  • ALVOW 0
  • TGTX 6
  • Target Price
  • ALVOW N/A
  • TGTX $40.67
  • AVG Volume (30 Days)
  • ALVOW N/A
  • TGTX 2.4M
  • Earning Date
  • ALVOW N/A
  • TGTX 02-26-2025
  • Dividend Yield
  • ALVOW N/A
  • TGTX N/A
  • EPS Growth
  • ALVOW N/A
  • TGTX N/A
  • EPS
  • ALVOW N/A
  • TGTX N/A
  • Revenue
  • ALVOW N/A
  • TGTX $264,790,000.00
  • Revenue This Year
  • ALVOW N/A
  • TGTX $44.12
  • Revenue Next Year
  • ALVOW N/A
  • TGTX $66.88
  • P/E Ratio
  • ALVOW N/A
  • TGTX N/A
  • Revenue Growth
  • ALVOW N/A
  • TGTX 39.53
  • 52 Week Low
  • ALVOW N/A
  • TGTX $12.84
  • 52 Week High
  • ALVOW N/A
  • TGTX $36.84
  • Technical
  • Relative Strength Index (RSI)
  • ALVOW N/A
  • TGTX 57.51
  • Support Level
  • ALVOW N/A
  • TGTX $32.61
  • Resistance Level
  • ALVOW N/A
  • TGTX $33.88
  • Average True Range (ATR)
  • ALVOW 0.00
  • TGTX 1.53
  • MACD
  • ALVOW 0.00
  • TGTX 0.28
  • Stochastic Oscillator
  • ALVOW 0.00
  • TGTX 75.73

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: